AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2020
Apr 30, 2020
30786_dirs_2020-04-30_8d757ebe-b1e0-40bd-af94-7bbe4639533f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO,BIOB)
CIK: 0000012208
Period of Report: 2020-04-29
Reporting Person: Last Andrew J. (EVP, Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-04-29 | Bio-Rad A Common Stock | M | 1000 | — | Acquired | 1025.9765 | Direct |
| 2020-04-29 | Bio-Rad A Common Stock | F | 346 | $436.27 | Disposed | 679.9765 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-04-29 | Restricted Stock Units | $0 | M | 1000 | Disposed | Bio-Rad A Common Stock (1000) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Includes 25.9765 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 3/31/2020.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4: The restricted stock units vest in five equal annual installments beginning on April 29, 2020.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13